Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Reservoir of Infection01:30

Reservoir of Infection

Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
Transmission of Pathogens01:24

Transmission of Pathogens

Pathogens spread from their reservoirs to susceptible hosts through three main routes: contact transmission, vehicle transmission, and vector transmission. Each route involves distinct mechanisms of transfer.Contact TransmissionThis category includes direct contact, indirect contact, and droplet transmission:Direct contact involves immediate physical interaction between individuals—such as a handshake—which can spread pathogens like Streptococcus pyogenes, the bacterium responsible for...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

High interobserver variability exists in grading appendiceal goblet cell adenocarcinoma using World Health Organization 5th edition criteria.

Histopathology·2026
Same author

Long-term antibody dynamics challenge the paradigm of lifelong homotypic immunity to dengue virus.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Integrated Surveillance Strategies and Clinical Characteristics of Arboviral Diseases in a Pediatric Cohort in Merida, Mexico, 2021-2023.

The American journal of tropical medicine and hygiene·2026
Same author

Epidemiological impacts of nonpharmaceutical interventions are modulated by immunity exposure trade offs.

Communications medicine·2026
Same author

Impact of Removing the Universal Hepatitis B Birth-Dose Vaccination in the US.

JAMA pediatrics·2026
Same author

Improving Assessment of Vaccine Effectiveness by Coupling Test-negative Design Studies with Survival Models.

Epidemiology (Cambridge, Mass.)·2026

関連する実験動画

Updated: Jul 8, 2026

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

パンデミックインフルエンザを源頭から封じ込めること.

Ira M Longini1, Azhar Nizam, Shufu Xu

  • 1Department of Biostatistics, The Rollins School of Public Health, Emory University, 1518 Clifton Road, N.E., Atlanta, GA 30322, USA. longini@sph.emory.edu

Science (New York, N.Y.)
|August 5, 2005
PubMed
まとめ

標的型抗ウイルス予防,予防接種前予防,隔離は,新興の鳥インフルエンザA (H5N1) 株を抑制することができます. 十分な抗ウイルス備蓄を備えた準備された応答は,繁殖数 (R0) が 1.60.0 以下である場合に有効です.

さらに関連する動画

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
03:53

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Published on: November 10, 2023

関連する実験動画

Last Updated: Jul 8, 2026

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV
03:53

Development of Multiplex Real-Time RT-qPCR Assays for the Detection of SARS-CoV-2, Influenza A/B, and MERS-CoV

Published on: November 10, 2023

科学分野:

  • エピデミオロジー エピデミオロジー
  • 感染症モデリング
  • 公共衛生の準備 公共衛生の準備

背景:

  • 高病原性鳥インフルエンザA (H5N1) は,大きなパンデミック脅威をもたらしています.
  • 新興のインフルエンザ株は,源頭で効果的な封じ込め戦略を必要とします.

研究 の 目的:

  • 新興インフルエンザ株を抑えるための介入の有効性を調査する.
  • パンデミックへの準備のために必要な抗ウイルス薬備蓄の規模を決定する.

主な方法:

  • 農村の東南アジアでストキャスティック型インフルエンザシミュレーションモデルを使用した.
  • 標的型抗ウイルス予防,隔離,予防接種の前回の効果を評価した.
  • 基本的繁殖数 (R0) に基づいて,抑制の成功を評価した.

主要な成果:

  • R0 <1.60の場合,標的型抗ウイルス薬で抑制の可能性が高いため,100,000~100万回の治療が必要となる.
  • 予防接種前は,抗ウイルス効果を高め,R0から2.1までの株の抑制を可能にします.
  • 組み合わせた介入は,R0が2.4.4まで高い株を含むことができる.

結論:

  • 標的型抗ウイルス予防は,新興インフルエンザを抑えるための重要な介入です.
  • 予防接種前と隔離は,封じ込め戦略の効果を大幅に高めます.
  • 抗ウイルス薬の備蓄を含む準備計画が,パンデミックリスクの軽減に不可欠です.